Skip to main content
BIOX
NASDAQ Life Sciences

欧盟因监管违规撤回含有Bioceres' HB4转基因strain的大豆粉

feedReported by Reuters
Sentiment info
Negative
Importance info
8
Price
$0.486
Mkt Cap
$31.368M
52W Low
$0.347
52W High
$5.175
Market data snapshot near publication time

summarizeSummary

来自阿根廷和巴西的大豆粉货物中含有Bioceres的专有HB4转基因生物(GMO)strain,因监管违规而被撤回欧盟市场。欧盟的食品和饲料快速警报系统标记了多批货物,因其含有未经批准的GMO,特别指出Bioceres开发的HB4 strain在欧盟不被允许。这是对Bioceres Crop Solutions的一个重大负面发展,因为它直接影响了核心产品在主要经济体中的商业化和市场准入。对于像Bioceres这样的公司来说,在关键市场的监管障碍和产品撤回可能会对未来的收入和增长前景产生重大影响。交易者应监测进一步的监管行动、关于检测方法的潜在上诉以及对Bioceres国际市场战略的更广泛影响。

在该公告发布时,BIOX的交易价格为$0.49,交易所为NASDAQ,所属行业为Life Sciences,市值约为$3136.8万。 52周交易区间为$0.35至$5.18。 这则新闻被评估为消极市场情绪,重要性评分为8/10。 来源:Reuters。


show_chartPrice Chart

Share this article

Copied!

feed BIOX - Latest Insights

BIOX
Apr 28, 2026, 11:23 AM EDT
Source: Reuters
Importance Score:
8
BIOX
Apr 28, 2026, 11:11 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
BIOX
Mar 24, 2026, 4:05 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
BIOX
Mar 17, 2026, 9:16 AM EDT
Filing Type: 6-K
Importance Score:
9
BIOX
Mar 13, 2026, 5:23 PM EDT
Filing Type: 6-K
Importance Score:
10
BIOX
Mar 13, 2026, 4:15 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
BIOX
Mar 05, 2026, 4:10 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
BIOX
Feb 05, 2026, 5:49 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
BIOX
Jan 21, 2026, 6:19 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
9
BIOX
Jan 20, 2026, 4:02 PM EST
Filing Type: 6-K
Importance Score:
9